---
layout: post
title: "【图解年报】精华制药：2021年归母净利润同比增长44.8%，约为1.6亿元"
date: 2022-03-29 18:07:27 +0800
categories: dongfangcaifuChoiceshuju
tags: 东方财富Choice数据新闻
---
<p>精华制药于2022年3月30日披露年报，公司2021年实现营业总收入13.6亿，同比增长6%；实现归母净利润1.6亿，同比增长44.8%；每股收益为0.2元。</p><img id="image7" class="autoimg" src="https://dfscdn.dfcfw.com/download/D2C153683393F5393362FE0E1894786BCB_w800h400.jpg" alt=""><p style="color:#61768C;font-size:0.9em;"></p><img id="image9" class="autoimg" src="https://dfscdn.dfcfw.com/download/D24DB60F5F67450C28B4CC7BBDFD378B6E_w800h400.jpg" alt=""><p><strong>期间费用率升高2.6%</strong></p><p>期间费用率为31.5%，较上年升高2.6%。</p><img id="image12" class="autoimg" src="https://dfscdn.dfcfw.com/download/D216371CC2CAF415DA6B8F2DDF12D77D22_w800h400.jpg" alt=""><p style="font-weight:bold;"></p><p style="margin: 10px 0; color: #999">免责声明：本文基于大数据生产，仅供参考，不构成任何投资建议，据此操作风险自担。</p><style>.autoimg {display: block;border: 0;max-width: 100%;margin: 0 auto;} .tbl {border-collapse: collapse;border-spacing: 0;text-align: center;width: 100% !important;} .tbl tr th, .tbl tr td {border: 1px solid #d8e6ff;padding: 5px;text-align: center;} .tbl tr th {color: #fff;background-color: #1c65b0;vertical-align: middle;} .tbl tr td {color: #000;background-color: #fff;} .imgtitle {text-indent: 0;text-align: center;color: #2395F1;} .autosrc {color: #999;display: block;text-align: center;margin-bottom: 5px;}</style>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203292326802947>

[返回东方财富Choice数据新闻](//finews.withounder.com/category/dongfangcaifuChoiceshuju.html)｜[返回首页](//finews.withounder.com/)